Home/Filings/4/0001127602-25-009265
4//SEC Filing

Patterson Sandra 4

Accession 0001127602-25-009265

CIK 0000882095other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 6:10 PM ET

Size

8.5 KB

Accession

0001127602-25-009265

Insider Transaction Report

Form 4
Period: 2025-03-10
Patterson Sandra
SVP, Controllership
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-10+1,95240,077 total
  • Tax Payment

    Common Stock

    2025-03-10$117.21/sh624$73,13939,453 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-03-101,9529,875 total
    Common Stock (1,952 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • [F2]Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
  • [F3]The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001968906

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 6:10 PM ET
Size
8.5 KB